Literature DB >> 24915266

Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.

Kasia J Lipska1, Joseph S Ross1, Holly K Van Houten2, David Beran3, John S Yudkin4, Nilay D Shah2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24915266      PMCID： PMC4133975          DOI： 10.1001/jama.2014.6316

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Newer insulins in type 2 diabetes.

Authors:  Edwin A M Gale
Journal:  BMJ       Date:  2012-09-11

2.  The insulin dilemma in resource-limited countries. A way forward?

Authors:  G V Gill; J S Yudkin; H Keen; D Beran
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

Review 3.  Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Authors:  K Horvath; K Jeitler; A Berghold; S H Ebrahim; T W Gratzer; J Plank; T Kaiser; T R Pieber; A Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

4.  Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.

Authors:  Sarah E Holden; Chris D Poole; Christopher Ll Morgan; Craig J Currie
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

5.  Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits.

Authors:  Adit A Ginde; Phillip G Blanc; Rebecca M Lieberman; Carlos A Camargo
Journal:  BMC Endocr Disord       Date:  2008-04-01       Impact factor: 2.763
  5 in total
  35 in total

Review 1.  Material need support interventions for diabetes prevention and control: a systematic review.

Authors:  Lily S Barnard; Deborah J Wexler; Darren DeWalt; Seth A Berkowitz
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

2.  Cost-Related Insulin Underuse Among Patients With Diabetes.

Authors:  Darby Herkert; Pavithra Vijayakumar; Jing Luo; Jeremy I Schwartz; Tracy L Rabin; Eunice DeFilippo; Kasia J Lipska
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

3.  Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.

Authors:  Bruce E Landon; Alan M Zaslavsky; Jeffrey Souza; John Z Ayanian
Journal:  J Gen Intern Med       Date:  2018-02-09       Impact factor: 5.128

4.  Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes.

Authors:  Nicole Ehrhardt; Sasan Fazeli; Sanjana Rao; Richard Amdur
Journal:  Diabetes Spectr       Date:  2020-05

Review 5.  Minimally Disruptive Medicine for Patients with Diabetes.

Authors:  Valentina Serrano; Gabriela Spencer-Bonilla; Kasey R Boehmer; Victor M Montori
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

Review 6.  Pursuit of a perfect insulin.

Authors:  Alexander N Zaykov; John P Mayer; Richard D DiMarchi
Journal:  Nat Rev Drug Discov       Date:  2016-03-18       Impact factor: 84.694

7.  Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.

Authors:  Jing Luo; Nazleen F Khan; Thomas Manetti; Jim Rose; Ani Kaloghlian; Balu Gadhe; Sachin H Jain; Joshua J Gagne; Aaron S Kesselheim
Journal:  JAMA       Date:  2019-01-29       Impact factor: 56.272

8.  Use of Post-acute Care Services and Readmissions After Left Ventricular Assist Device Implantation in Privately Insured Patients.

Authors:  Shannon M Dunlay; Lindsey R Haas; Jeph Herrin; Stephanie R Schilz; John M Stulak; Sudhir S Kushwaha; Nilay D Shah
Journal:  J Card Fail       Date:  2015-06-18       Impact factor: 5.712

9.  Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Authors:  Xilin Zhou; Sundar S Shrestha; Hui Shao; Ping Zhang
Journal:  Diabetes Care       Date:  2020-07-31       Impact factor: 19.112

Review 10.  Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Authors:  David Beran; Margaret Ewen; Kasia Lipska; Irl B Hirsch; John S Yudkin
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.